David Goel Matrix Capital Management Company
David Goel is a co-founder of Matrix Capital Management, a technology-oriented investment firm with public and private market activities. Matrix is known for concentrated positions in software, semiconductor, and internet-related businesses. Goel’s filings are monitored for high-conviction technology themes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$274M |
| 2 |
Autodesk
ADSK
|
+$62M |
| 3 |
Synopsys
SNPS
|
+$48.3M |
| 4 |
ALTR
Altair Engineering Inc
ALTR
|
+$8.49M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 72.24% |
| 2 | Consumer Discretionary | 11.19% |
| 3 | Industrials | 11.07% |
| 4 | Healthcare | 5.09% |
| 5 | Materials | 0.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
NVIDIA
NVDA
$5.2T
| $1.38B | 16.51% |
31,637,000
| – | – |
|
2
GlobalFoundries
GFS
$26.4B
| $992M | 11.9% |
17,048,000
| – | – |
|
3
Applied Materials
AMAT
$391B
| $976M | 11.71% |
7,052,700
| – | – |
|
4
Amazon
AMZN
$2.79T
| $933M | 11.19% |
7,335,828
| – | – |
|
5
TransDigm Group
TDG
$66.4B
| $923M | 11.07% |
1,094,900
| – | – |
|
|
6
Marvell Technology
MRVL
$213B
| $713M | 8.55% |
13,166,824
+4,634,127
| +54% | +$274M |
|
|
ALTR
7
DELISTED
Altair Engineering Inc
ALTR
| $707M | 8.48% |
11,300,457
+126,257
| +1% | +$8.49M |
|
8
Workday
WDAY
$49.4B
| $341M | 4.09% |
1,586,043
| – | – |
|
|
9
Synopsys
SNPS
$76.2B
| $329M | 3.95% |
717,735
+108,000
| +18% | +$48.3M |
|
10
ASML
ASML
$677B
| $293M | 3.51% |
497,200
| – | – |
|
11
Zentalis Pharmaceuticals
ZNTL
$363M
| $280M | 3.36% |
13,959,973
| – | – |
|
12
Qualcomm
QCOM
$169B
| $207M | 2.48% |
1,861,000
| – | – |
|
|
13
Autodesk
ADSK
$53.6B
| $85.7M | 1.03% |
414,000
+295,000
| +248% | +$62M |
|
14
Adaptive Biotechnologies
ADPT
$4.15B
| $63.1M | 0.76% |
11,572,590
| – | – |
|
15
Aura Biosciences
AURA
$809M
| $48.1M | 0.58% |
5,362,870
| – | – |
|
16
Perimeter Solutions
PRM
$5.15B
| $33.9M | 0.41% |
7,462,500
| – | – |
|
|
ADAP
17
DELISTED
Adaptimmune Therapeutics
ADAP
| $30.4M | 0.36% |
38,974,185
| – | – |
|
|
VTYX
18
DELISTED
Ventyx Biosciences
VTYX
| $3.12M | 0.04% |
89,900
| – | – |
|
19
Zscaler
ZS
$29.4B
| $2.86M | 0.03% |
18,405
| – | – |
|
Similar funds
David Goel's Q3 2023 Portfolio in Review
As of Q3 2023, David Goel held 19 positions worth $8.34B, down 3.1% from $8.61B the previous quarter. Its ten largest holdings account for 91% of the portfolio.
David Goel deployed $392M of net new capital in Q3 2023, adding to 4 existing holdings.
By sector, the portfolio is most concentrated in Technology at 72% of assets, up from 70% a quarter earlier, followed by Consumer Discretionary and Industrials.
- David Goel added most to Marvell Technology in Q3 2023, an estimated $274M increase.
- David Goel's ten largest holdings make up 91% of its $8.34B portfolio in Q3 2023.
- David Goel opened 0 new positions and closed 0 in Q3 2023.
- David Goel's portfolio value fell 3.1% quarter-over-quarter to $8.34B.
Based on Matrix Capital Management Company's 13F filing for Q3 2023, filed 14 Nov 2023.